Tokushima University / Educator and Researcher Directory --- Yamamoto, Yuri

Search:

Tokushima University ⟩ University Hospital ⟩ Central Clinical Facilities ⟩ Department of Community and Obstetrics and Gynecology ⟩
Tokushima University ⟩ University Hospital ⟩ Clinical Division ⟩ Department of Pediatrics,Obstetrics and Gynecology ⟩ Obstetrics snd Gynecology ⟩

(Files for researchmap) [PDF manual] [Auto-propagate to researchmap]

Research

Field of Study

Subject of Study

Book / Paper

Book:

1.	Takeshi Iwasa, 柳原里江 and Yuri Yamamoto : ランダムスタート法, 株式会社中外医学社, May 2023.
2.	Takeshi Iwasa, Saki Minato and Yuri Yamamoto : 多嚢胞性卵巣症候群(PCOS), 総合医学社, Sep. 2021.

Academic Paper (Judged Full Paper):

1.	内芝舞実, Yuri Yamamoto, 宮本容子, 吉田友紀子, Hiroki Noguchi, Asuka Takeda, Saki Minato, 鎌田周平, 白河綾, Eishi Sogawa, Ayuka Mineda, Atsuko Yoshida, Takashi Kaji, 苛原稔 and Takeshi Iwasa : 当院におけるART妊娠者でのNIPT受検率について, 徳島産婦人科医報, No.56, 3-7, 2023.
2.	Ayako Suto, Yuya Yano, Yuri Yamamoto, Hiroki Noguchi, Asuka Takeda, Shota Yamamoto, Tomohiro Kagawa, Kanako Yoshida, Kenji Hinokio, Akira Kuwahara, Toshiyuki Yasui and Takeshi Iwasa : Effects of activation with a Ca ionophore and roscovitine on the development of human oocytes that failed to fertilize after ICSI., The Journal of Medical Investigation : JMI, Vol.70, No.3.4, 321-324, 2023. (Summary) Sequential treatment with an Ca ionophore and roscovitine activates oocytes that remain unfertilized after ICSI. In TESE-ICSI, the activation rate tended to be increased by the co-administration of roscovitine with a Ca ionophore. J. Med. Invest. 70 : 321-324, August, 2023. (Keyword) Humans / male / Ionophores / Sperm Injections, Intracytoplasmic / Roscovitine / Semen / Oocytes (Link to Publication Site) ● Publication site (DOI): 10.2152/jmi.70.321 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 37940514 ● Search Scopus @ Elsevier (PMID): 37940514 ● Search Scopus @ Elsevier (DOI): 10.2152/jmi.70.321 (DOI: 10.2152/jmi.70.321, PubMed: 37940514)
3.	Saki Minato, Yuri Yamamoto, 野口拓樹, Maimi Uchishiba, Shuhei Kamada, 谷口友香, 河北貴子, Minoru Irahara and Takeshi Iwasa : 当院における精巣内精子採取術・顕微授精(testicular sperm extraction-intracytoplasmic sperm injection: TESE-ICSI)の治療成績と周産期予後の検討, Modern Trends in Obstetrics & Gynecology, Vol.71, No.1, 93-98, 2022. (Keyword) TESE / ICSI / perinatal prognosis (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1520857757594822656 (CiNii: 1520857757594822656)
4.	Shuhei Kamada, Yuri Yamamoto, Hidenori Aoki, Kou Tamura, Asuka Takeda, Saki Minato, Rie Masaki, Rie Yanagihara, Noriko Hayashi, Yuya Yano, Junki Imaizumi, Tomohiro Kagawa, Atsuko Yoshida, Takako Kawakita, Minoru Irahara and Takeshi Iwasa : A novel PCOS rat model and an evaluation of its reproductive, metabolic, and behavioral phenotypes., Reproductive Medicine and Biology, Vol.21, No.1, e12416, 2021. (Summary) Although animal models of PCOS have been used in many studies, none of them can reproduce both the reproductive and metabolic phenotypes of PCOS. In addition, behavioral parameters have not been evaluated in PCOS animal models. We tried to produce an improved rat model of PCOS, and the reproductive, metabolic, and behavioral phenotypes of the model rats were evaluated. Female rats were implanted with silicon tubes containing oil-dissolved dihydrotestosterone (Oil-DHT) as a new PCOS model. Their phenotypes were compared with those of conventional PCOS model rats (DHT), into which tubes containing crystalline DHT were implanted, and non-DHT-treated rats (control). Both the Oil-DHT and DHT rats showed greater body weight gain, food intake, and fat depot weight than the control rats. Furthermore, these groups showed fewer estrous stages and increased numbers of cystic follicles. The DHT rats exhibited lower ovarian and uterine weights than the control rats, whereas no such changes were observed in the Oil-DHT rats. The Oil-DHT and DHT rats showed less locomotor activity in the light phase than the control rats. Our proposed PCOS model reproduced both the reproductive and metabolic phenotypes of PCOS and may have potential for PCOS research. (Tokushima University Institutional Repository) ● Metadata: 117712 (Link to Publication Site) ● Publication site (DOI): 10.1002/rmb2.12416 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 34934399 ● Search Scopus @ Elsevier (PMID): 34934399 ● Search Scopus @ Elsevier (DOI): 10.1002/rmb2.12416 (Tokushima University Institutional Repository: 117712, DOI: 10.1002/rmb2.12416, PubMed: 34934399)
5.	Takeshi Iwasa, Toshiya Matsuzaki, Yiliyasi Mayila, Rie Yanagihara, Yuri Yamamoto, Takako Kawakita, Akira Kuwahara and Minoru Irahara : Oxytocin treatment reduced food intake and body fat and ameliorated obesity in ovariectomized female rats., Neuropeptides, Vol.75, 49-57, 2019. (Summary) Recent studies have shown that oxytocin reduces food intake and body weight gain and promotes lipolysis in some species, including humans. Interestingly, these effects of oxytocin are more marked in obese individuals. Although the menopausal loss of ovarian function induces increased visceral adiposity and some metabolic disorders, no safe medical interventions for these conditions have been established. In this study, we evaluated the effects of oxytocin on appetite, body weight, and fat mass in ovariectomized rats. Six-day oxytocin treatment attenuated cumulative food intake and body weight gain, and reduced visceral and subcutaneous fat weight and adipocyte cell area in ovariectomized rats. Blood examinations indicated that 6-day oxytocin treatment did not alter renal or hepatic functions. Instead, it might prevent ovariectomy-induced liver damage. In addition, acute oxytocin treatment did not affect body temperature or locomotor activity. These results indicate that oxytocin might be useful for treating or preventing menopause-induced metabolic disorders, without causing any adverse effects. (Link to Publication Site) ● Publication site (DOI): 10.1016/j.npep.2019.03.002 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 30885500 ● Search Scopus @ Elsevier (PMID): 30885500 ● Search Scopus @ Elsevier (DOI): 10.1016/j.npep.2019.03.002 (DOI: 10.1016/j.npep.2019.03.002, PubMed: 30885500)
6.	Takeshi Iwasa, 谷口友香, 中山聡一朗, Naoto Yonetani, Atsuko Yoshida, Akiko Abe, Yuri Yamamoto, Takashi Kaji, Akira Kuwahara, Toshiya Matsuzaki and Minoru Irahara : Current status of chromosomal analysis in couples with recurrent miscarriage at Tokushima University Hospital, Modern Trends in Obstetrics & Gynecology, Vol.67, No.1, 21-24, 2018. (Keyword) 不育症 / 習慣流産 / 染色体検査 / recurrent miscarriage / chromosome analysis (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1520572359817582976 (CiNii: 1520572359817582976)
7.	Yuka Taniguchi, Akira Kuwahara, Ayaka Tachibana, Yuya Yano, Kiyohito Yano, Yuri Yamamoto, Mikio Yamasaki, Takeshi Iwasa, Kenji Hinokio, Toshiya Matsuzaki and Minoru Irahara : Intra-follicular kisspeptin levels are related to oocyte maturation and gonadal hormones in patients who are undergoing assisted reproductive technology., Reproductive Medicine and Biology, Vol.16, No.4, 380-385, 2017. (Summary) To assess the kisspeptin concentrations in follicular fluid and their relationship with clinical outcomes during assisted reproductive technology. Thirty-nine patients who were aged 24-40 years and underwent oocyte retrieval for in vitro fertilization/intracytoplasmic sperm injection participated in this study In 65 follicular fluid samples that had been obtained from 30 patients and their blood samples, the kisspeptin levels were measured in order to investigate the correlations with their gonadal hormone levels. Venous blood samples were collected from 14 patients to investigate their plasma kisspeptin levels across different phases of assisted reproductive technology. The follicular fluid kisspeptin level was significantly higher than that of the plasma level and was positively associated with the follicular fluid estradiol concentration and with the serum estradiol and number of mature oocytes. In the plasma, the maximum concentration of kisspeptin was observed on the day of ovum pick-up and on the day of embryo transfer during ovarian stimulation for assisted reproductive technology. Kisspeptin was present in the follicular fluid and the plasma kisspeptin concentration was affected by ovarian stimulation. Kisspeptin appears to affect oocyte maturation and ovulation. (Tokushima University Institutional Repository) ● Metadata: 112881 (Link to Publication Site) ● Publication site (DOI): 10.1002/rmb2.12056 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 29259492 ● Search Scopus @ Elsevier (PMID): 29259492 ● Search Scopus @ Elsevier (DOI): 10.1002/rmb2.12056 (Tokushima University Institutional Repository: 112881, DOI: 10.1002/rmb2.12056, PubMed: 29259492)
8.	Mikio Yamasaki, Akira Kuwahara, Takeshi Iwasa, Yuri Yamamoto, Yuka Taniguchi, Yuya Yano, Sumika Matsui, Toshiya Matsuzaki and Minoru Irahara : Development-related changes in the expression of the ovarian Kiss1 and Kiss1r genes and their sensitivity to human chorionic gonadotropin in prepubertal female rats., The Journal of Reproduction and Development, Vol.63, No.4, 409-414, 2017. (Summary) Kisspeptin, which is encoded by the Kiss1 gene, and its receptor, the G protein-coupled receptor 54 (Kiss1r), play important roles in the regulation of reproductive functions in mammals. Several studies have shown that the Kiss1 and Kiss1r genes are expressed in the rat, primate, and human ovaries, and that the ovarian kisspeptin system plays a pivotal role in ovulation at the proestrous stage in adulthood. The purpose of this study was to evaluate development-related changes in the expression of ovarian Kiss1 and Kiss1r genes and in kisspeptin levels, and to identify the regulatory factors for these genes during the prepubertal period. The serum kisspeptin level was also measured to examine whether ovarian kisspeptin affects serum kisspeptin levels. Variations in the ovarian Kiss1 and Kiss1r mRNA levels were observed during the prepubertal period in female rats, with levels peaking around postnatal days 20 and 15, respectively. Nevertheless, the ovarian kisspeptin content per total protein level was stably maintained. Serum kisspeptin levels at postnatal days 30 and 35 were higher than those at earlier postnatal days. The pattern of the ovarian Kiss1 mRNA levels was similar to that of the serum luteinizing hormone (LH) levels, and the ovarian Kiss1 mRNA level increased after injection with human chorionic gonadotropin (HCG) on postnatal day 20, but not on postnatal days 10 and 30. These data indicate that ovarian Kiss1 and Kiss1r mRNA levels are increased on postnatal days 20 and 15, respectively, and that changes in the serum LH level and the ovarian sensitivity to LH may be involved in the alteration of ovarian Kiss1 mRNA levels. (Keyword) Animals / Chorionic Gonadotropin / Female / Gene Expression Regulation, Developmental / Kisspeptins / Ovary / Rats / Rats, Sprague-Dawley / Receptors, Kisspeptin-1 (Tokushima University Institutional Repository) ● Metadata: 112975 (Link to Publication Site) ● Publication site (DOI): 10.1262/jrd.2016-179 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 28552864 ● Search Scopus @ Elsevier (PMID): 28552864 ● Search Scopus @ Elsevier (DOI): 10.1262/jrd.2016-179 (Tokushima University Institutional Repository: 112975, DOI: 10.1262/jrd.2016-179, PubMed: 28552864)
9.	Yuu Tanaka, Akira Kuwahara, Kenjiro Ushigoe, Yuya Yano, Yuka Taniguchi, Yuri Yamamoto, Toshiya Matsuzaki, Toshiyuki Yasui and Minoru Irahara : Expression of cytokine-induced neutrophil chemoattractant suppresses tumor necrosis factor alpha expression and thereby prevents the follicles from undergoing atresia and apoptosis., Reproductive Medicine and Biology, Vol.16, No.2, 157-165, 2017. (Summary) Cytokine-induced neutrophil chemoattractant (CINC/gro) is a CXC family chemokine, similar to interleukin-8 in rats, and is one of the factors that regulates ovulation. However, the mechanism that regulates atresia of the ovaries postovulation is not clearly defined. Whether antibody-blocking of CINC/gro can alter the number of ovulated oocytes and modulate neutrophil infiltration was investigated. The effect of the antibody on the level of inflammatory cytokine production and follicular atresia was examined. Apoptosis was measured by the terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) method and via analysis of the messenger RNA expression of Bcl-2 and Bcl2-associated X (Bax). The anti-CINC/gro antibody treatment decreased the number of ovulated oocytes. The messenger RNA levels of cyclooxygenase-2 and interleukin-1 beta were decreased by the antibody treatment, whereas that of tumor necrosis factor (TNF) alpha was increased. The TUNEL analysis revealed a larger number of apoptotic cells in the antibody group, compared with those in the control group, as well as a significant increase in the Bax/Bcl-2 ratio 24 hours after human chorionic gonadotropin administration. These findings suggest that ovulation is accelerated by neutrophil infiltration into the theca layer. The CINC/gro appears to synergize with interleukin-1 beta for ovulation. By contrast, the data suggest that CINC/gro expression suppresses TNF alpha expression and that CINC/gro expression therefore prevents the follicles from undergoing atresia and apoptosis. (Tokushima University Institutional Repository) ● Metadata: 113212 (Link to Publication Site) ● Publication site (DOI): 10.1002/rmb2.12022 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 29259464 ● Search Scopus @ Elsevier (PMID): 29259464 ● Search Scopus @ Elsevier (DOI): 10.1002/rmb2.12022 (Tokushima University Institutional Repository: 113212, DOI: 10.1002/rmb2.12022, PubMed: 29259464)
10.	Kanako Yoshida, Takeshi Katou, Yuri Yamamoto, Yuu Tanaka and Minoru Irahara : 骨盤内膿瘍に対する腹腔鏡手術の有用性, Modern Trends in Obstetrics & Gynecology, Vol.59, No.1, 59-63, 2010. (Summary) 骨盤内膿瘍に対する治療は，抗生剤による薬物療法が主体であるが，抗生剤無効例や，消化管から発生した膿瘍との鑑別を要する症例では外科的アプローチが必要となる．骨盤内膿瘍の場合，炎症による癒着が強いことが多く，手術は比較的難易度が高い．しかし，高度の炎症で疲弊した患者の負担を軽減するために，近年では腹腔鏡手術が積極的に導入されており，当院でも可能な限り腹腔鏡手術で対応している．抗生剤による治療が無効であった付属器膿瘍に対して腹腔鏡下手術を施行した4症例について報告する．4例とも輸血を要するような出血はなく，また他臓器損傷もなかった．術後は，速やかに炎症所見が改善し特に問題なく経過した．骨盤内膿瘍に対する腹腔鏡手術は，ドレナージによりすみやかな炎症軽減が可能であり，かつ低侵襲であることから有用性は高い．一方で，(汎発性腹膜炎などで，)腸管麻痺を伴う症例では，腸管の膨隆のため腹腔鏡下の視野確保が困難であり，腹腔鏡手術の適応は慎重であるべきであると考える． (Keyword) 付属器膿瘍 / 腹腔鏡 / tubo-ovaruan abscess / laparoscopic surgery (Tokushima University Institutional Repository) ● Metadata: 113614 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1050282813437686400 (Tokushima University Institutional Repository: 113614, CiNii: 1050282813437686400)

Academic Paper (Unrefereed Paper):

1.	Takeshi Iwasa, Hiroki Noguchi, Risa Tanano, Erika Yamanaka, Asuka Takeda, Kou Tamura, Hidenori Aoki, Tatsuro Sugimoto, Hikari Sasada, Takaaki Maeda, Saki Minato, Shota Yamamoto, Hiroaki Inui, Tomohiro Kagawa, Atsuko Yoshida, Ayuka Mineda, Mari Nii, Riyo Kinouchi, Kanako Yoshida, Yuri Yamamoto and Takashi Kaji : Age-Dependent Changes in the Effects of Androgens on Female Metabolic and Body Weight Regulation Systems in Humans and Laboratory Animals., International Journal of Molecular Sciences, Vol.24, No.23, 16567, 2023. (Summary) In recent years, the effects of androgens on metabolic and body weight regulation systems and their underlying mechanisms have been gradually revealed in females. In women and experimental animals of reproductive age, androgen excess can adversely affect metabolic functioning, appetite, and body weight regulation. In addition, excess androgens can increase the risk of metabolic disorders, such as obesity, insulin resistance, and diabetes. These unfavorable effects of androgens are induced by alterations in the actions of hypothalamic appetite-regulatory factors, reductions in energy expenditure, insulin resistance in skeletal muscle, and β-cell dysfunction. Interestingly, these unfavorable effects of androgens on metabolic and body-weight regulation systems are neither observed nor evident in ovariectomized animals and post-menopausal women, indicating that the adverse effects of androgens might be dependent on the estrogen milieu. Recent findings may provide novel sex- and age-specific strategies for treating metabolic diseases. (Keyword) Animals / Humans / female / Androgens / Insulin Resistance / Obesity / Metabolic Diseases / Animals, Laboratory / Polycystic Ovary Syndrome (Link to Publication Site) ● Publication site (DOI): 10.3390/ijms242316567 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 38068890 ● Search Scopus @ Elsevier (PMID): 38068890 ● Search Scopus @ Elsevier (DOI): 10.3390/ijms242316567 (DOI: 10.3390/ijms242316567, PubMed: 38068890)
2.	田村公, Yuri Yamamoto, Saki Minato, 柳原里江, Shuhei Kamada, 谷口友香, 阿部彰子, Masato Nishimura, Minoru Irahara and Takeshi Iwasa : 子宮内膜癌・子宮内膜異型増殖症に対する妊孕性温存治療の治療効果と妊娠成績，周産期予後, Modern Trends in Obstetrics & Gynecology, Vol.70, No.1, 123-128, 2021. (Keyword) 子宮内膜癌 / 子宮内膜異型増殖症 / MPA療法 / 妊孕性温存 / endometrial cancer / atypical endometrial hyperplasia / medroxyprogesterone acetate (MPA) treatment / シキュウナイマクガン / シキュウナイマクイケイゾウショクショウ / MPA リョウホウ / ニンヨウセイオンゾン (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1520853835559930496 (CiNii: 1520853835559930496)

Review, Commentary:

1.	Takeshi Iwasa, 野口拓樹, Maimi Uchishiba and Yuri Yamamoto : 多胎二卵性, 一卵性多胎, Clinical Gynecology and Obstetrics, Vol.76, No.11, 1112-1117, Nov. 2022. (Link to Publication Site) ● Publication site (DOI): 10.11477/mf.1409210818 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390856981718899968 ● Search Scopus @ Elsevier (DOI): 10.11477/mf.1409210818 (DOI: 10.11477/mf.1409210818, CiNii: 1390856981718899968)
2.	Takeshi Iwasa, Maimi Uchishiba, Hiroki Noguchi and Yuri Yamamoto : 黄体ホルモン製剤の種類と使い方, Obstetrical and Gynecological Practice, Vol.71, No.10, 1277-1280, Sep. 2022.
3.	Takeshi Iwasa, 野口拓樹 and Yuri Yamamoto : 黄体ホルモンと生殖補助医療, Obstet. Gynecol. (tokyo), Vol.89, No.9, 963-967, Aug. 2022.
4.	Takeshi Iwasa, Saki Minato and Yuri Yamamoto : 新鮮胚移植と凍結胚移植の安全性, Clinical Gynecology and Obstetrics, Vol.76, No.4, 122-125, Apr. 2022. (Link to Publication Site) ● Publication site (DOI): 10.11477/mf.1409210652 (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1390010457642203648 ● Search Scopus @ Elsevier (DOI): 10.11477/mf.1409210652 (DOI: 10.11477/mf.1409210652, CiNii: 1390010457642203648)
5.	Takeshi Iwasa, Rie Yanagihara and Yuri Yamamoto : 卵巣老化とPGT-A, Obstet. Gynecol. (tokyo), Vol.88, No.8, 952-957, Aug. 2021.
6.	Takeshi Iwasa, Rie Yanagihara and Yuri Yamamoto : 【画像! エキスパート直伝産婦人科画像診断】生殖内分泌 .機能性囊胞, 黄体囊胞, 排卵・黄体,卵巣出血, Obstet. Gynecol. (tokyo), Vol.88, No.Suppl, 255-258, Mar. 2021.
7.	Takeshi Iwasa, Shuhei Kamada and Yuri Yamamoto : 耐糖能異常, Obstetrical and Gynecological Practice, Vol.69, No.13, 1593-1596, Dec. 2020.
8.	Takeshi Iwasa, Yuri Yamamoto and 桑原章 : がん治療後の内分泌環境の変化, Journal of Fertility Preservation, Vol.3, No.1, 202-204, Feb. 2020. (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1523669555939849344 (CiNii: 1523669555939849344)
9.	Takeshi Iwasa, Toshiya Matsuzaki, Kiyohito Yano, Yiliyasi Mayila, Rie Yanagihara, Yuri Yamamoto, Akira Kuwahara and Minoru Irahara : Effects of Low Energy Availability on Reproductive Functions and Their Underlying Neuroendocrine Mechanisms., Journal of Clinical Medicine, Vol.7, No.7, Jul. 2018. (Summary) It is known that metabolic disturbances suppress reproductive functions in females. The mechanisms underlying metabolic and nutritional effects on reproductive functions have been established based on a large body of clinical and experimental data. From the 1980s to 1990s, it was revealed that disrupted gonadotropin-releasing hormone (GnRH) secretion is the main cause of reproductive impairments in metabolic and nutritional disorders. From the late 1990s to early 2000s, it was demonstrated that, in addition to their primary functions, some appetite- or metabolism-regulating factors affect GnRH secretion. Furthermore, in the early 2000s, kisspeptin, which is a potent positive regulator of GnRH secretion, was newly discovered, and it has been revealed that kisspeptin integrates the effects of metabolic status on GnRH neurons. Recent studies have shown that kisspeptin mediates at least some of the effects of appetite- and metabolism-regulating factors on GnRH neurons. Thus, kisspeptin might be a useful clinical target for treatments aimed at restoring reproductive functions in individuals with metabolic or nutritional disturbances, such as those who exercise excessively, experience marked weight loss, or suffer from eating disorders. This paper presents a review of what is currently known about the effects of metabolic status on reproductive functions and their underlying mechanisms by summarizing the available evidence. (Tokushima University Institutional Repository) ● Metadata: 117743 (Link to Publication Site) ● Publication site (DOI): 10.3390/jcm7070166 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 29976877 ● Search Scopus @ Elsevier (PMID): 29976877 ● Search Scopus @ Elsevier (DOI): 10.3390/jcm7070166 (Tokushima University Institutional Repository: 117743, DOI: 10.3390/jcm7070166, PubMed: 29976877)

Proceeding of International Conference:

1.	YAMASAKI Mikio, Akira Kuwahara, TANIGUCHI Yuka, Yuri Yamamoto, Takeshi Iwasa, HINOKIO Kenji, Toshiya Matsuzaki and Minoru Irahara : Comparison of AMH and FSH an indicator of ovarian reserve in ART., IFFS/JSRM International Meeting,2015, Yokohama, Apr. 2015.
2.	TANAKA Yu, Akira Kuwahara, USHIGOE Kenjiro, YANO Yuya, TANIGUCHI Yuka, Yuri Yamamoto and Toshiya Matsuzaki : The role of CINC/gro in the rat ovulatory process., IFFS/JSRM International Meeting,2015, Yokohama, Apr. 2015.
3.	Yuri Yamamoto, Akira Kuwahara, YANO Yuya, TANIGUCHI Yuka, YAMASAKI MIkio, HINOKIO Kenji and Minoru Irahara : Clinical significance of serum hCG in early pregnancy periods in ART., IFFS/JSRM International Meeting,2015, Yokohama, Apr. 2015.
4.	Akira Kuwahara, HINOKIO Kenji, TANIGUCHI Yuka, Yuri Yamamoto, YAMASAKI Mikio, Takeshi Iwasa and Minoru Irahara : Clinical significance of estradiol and transvaginal ultrasonography for pregnancy outcomes in natural frozen-thawed blastcyst transfer cycles., IFFS/JSRM International Meeting,2015, Yokohama, Apr. 2015.
5.	Akiko Abe, Masato Nishimura, Eri Takiguchi, Takako Kawakita, TANIGUCHI Yuka, Yuri Yamamoto, YAMASAKI Mikio, Takeshi Iwasa, Akira Kuwahara, Toshiya Matsuzaki and Minoru Irahara : Survey on oncologist and gynecologist concerned with fertility for cancer survivors in reproductive age., IFFS/JSRM International Meeting,2015, Yokohama, Apr. 2015.
6.	Masato Nishimura, Eri Takiguchi, Takako Kawakita, Akiko Abe, TANIGUCHI Yuka, Yuri Yamamoto, YAMASAKI Mikio, Takeshi Iwasa, Akira Kuwahara, Toshiya Matsuzaki and Minoru Irahara : Efficacy and pregnant outcomes of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical endometrial hyperplasia in young women., IFFS/JSRM International Meeting,2015, Yokohama, Apr. 2015.

Proceeding of Domestic Conference:

1.	Riyo Kinouchi, 加藤剛志, Asuka Takeda, 新垣亮輔, 内芝舞実, Tomohiro Kagawa, 白河綾, Ayuka Mineda, Yuri Yamamoto, Kanako Yoshida and Takeshi Iwasa : 前方シングルメッシュによるLSCまたはRSCによるPーQOLの改善についての検討, 第75回中国四国産科婦人科学会総会ならびに学術講演会, Sep. 2023.
2.	Riyo Kinouchi, 加藤剛志, Asuka Takeda, 新垣亮輔, 内芝舞実, Tomohiro Kagawa, 白河綾, Ayuka Mineda, Yuri Yamamoto, Kanako Yoshida and Takeshi Iwasa : 前方シングルメッシュによるLSCまたはRSCによるP-QOLの改善についての検討, 第63回日本産科婦人科内視鏡学会学術講演会, Sep. 2023.
3.	Kanako Yoshida, Takeshi Katou, 武田明日香, Ryosuke Arakaki, 今泉絢貴, Tomohiro Kagawa, Ayuka Mineda, 河北貴子, Yuri Yamamoto, 苛原稔 and Takeshi Iwasa : ワークショップ:効率よくTLH上達を目指すための当科での取り組み, 第62回日本産婦人科内視鏡学会, Sep. 2022.
4.	Yuri Yamamoto and Takeshi Katou : 子宮腺筋症核出術後に不妊治療を行うも妊娠せず子宮全摘術をおこなった1例, 第60回日本産科婦人科内視鏡学会学術講演会, Dec. 2020.
5.	清重尚希, Ryohei Sumitani, 水口槙子, 中村昌史, Masahiro Oura, Kimiko Sogabe, 高橋真美子, Takeshi Harada, Shiroh Fujii, 賀川久美子, Masahiro Abe, Shingen Nakamura, Hirokazu Miki, 曽賀愛未, 一宮由貴 and Yuri Yamamoto : 急性転化をきたしたAYA世代慢性骨髄性白血病の1例, Shikoku Acta Medica, Vol.76, No.5-6, 354-355, Dec. 2020. (Keyword) 同種移植抗腫瘍剤(治療的利用) *白血病-BCR-ABL陽性慢性骨髄性(診断,治療,薬物療法) 急性転化(白血病) 障害者の子供造血幹細胞移植家族介護者ヒト青年期(13~18) 女
6.	Yuri Yamamoto, 桑原章, Akiko Abe, Takeshi Iwasa, 倉橋浩樹 and Minoru Irahara : 徳島大学病院における初めての着床前診断(PGT-M)の経験, 第72回日本産科婦人科学会学術集会, Apr. 2020.
7.	Akiko Abe, Takeshi Iwasa, Yuri Yamamoto, Masami Morimoto, Shingen Nakamura and Akira Kuwahara : 徳島県におけるがん生殖医療の現状と課題, Journal of Fertility Preservation, Vol.3, No.1, 106, Jan. 2020. (Keyword) 腫瘍地域社会ネットワーク徳島県 *妊孕性温存ヒト女
8.	Takeshi Iwasa, Toshiya Matsuzaki, Akiko Abe, 柳原理江, Yuri Yamamoto, Tomohiro Kagawa, Ayuka Mineda, Masato Nishimura, Akira Kuwahara and Minoru Irahara : 子宮内膜異型増殖症・初期子宮体癌患者に対する黄体ホルモン療法の治療成績，妊娠成績および周産期予後, 第72回中国四国日本産科婦人科学会学術講演会, Sep. 2019.
9.	Takeshi Iwasa, Yuri Yamamoto, Akiko Abe, Akira Kuwahara, Masato Nishimura, 松崎敏也 and Minoru Irahara : 子宮内膜異型増殖症・初期子宮体癌患者に対する黄体ホルモン療法の治療成績，妊娠成績および周産期予後, 第10回日本がん・生殖医療学会, Feb. 2019.

Et cetera, Workshop:

1.	Yuri Yamamoto : 徳島県におけるがん生殖ネットワーク形成の取り組み, 第35回徳島大学産科婦人科関連病院臨床検討会, Sep. 2021.

Grants-in-Aid for Scientific Research (KAKEN Grants Database @ NII.ac.jp)

女性においてアンドロゲンが栄養代謝機能に及ぼす影響とその機序に関する検討 (Project/Area Number: 21K09518 )
Search by Researcher Number (90622879)